SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-030094
Filing Date
2024-02-09
Accepted
2024-02-09 16:27:03
Documents
17
Period of Report
2024-02-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d737228d8k.htm   iXBRL 8-K 27848
2 EX-1.1 d737228dex11.htm EX-1.1 198418
3 EX-5.1 d737228dex51.htm EX-5.1 11185
7 GRAPHIC g737228dsp45.jpg GRAPHIC 10313
  Complete submission text file 0001193125-24-030094.txt   432697

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA stro-20240209.xsd EX-101.SCH 2853
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20240209_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20240209_pre.xml EX-101.PRE 10814
18 EXTRACTED XBRL INSTANCE DOCUMENT d737228d8k_htm.xml XML 3503
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 24615432
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)